ArticleDrug, healthcare and patient safety2013

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports.

David G Perahia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.